Literatur
- 1
Apfelbaum M, Vague P, Ziegler O, Hanotin C, Thomas F, Leutenegger E.
Long-term maintenance
of weight loss after a very-low-calorie diet: a randomized blinded
trial of the efficacy and tolerability of sibutramine.
Am
J Med.
1999;
106
179-184
- 2
Argyropoulos G, Brown A M, Willi S M. et al .
Effects of mutations in the human uncoupling
protein 3 gene on the respiratory quotient and fat oxidation in
severe obesity and type 2 diabetes.
J Clin Invest.
1998;
102
1345-1351
- 3
Arsenijevic D, Onuma H, Pecqueur C. et al .
Disruption of the uncoupling protein-2
gene in mice reveals a role in immunity and reactive oxygen species
production.
Nat Genet.
2000;
26
435-439
- 4
Bogardus C, Lillioja S, Ravussin E. et al .
Familial dependence of the resting metabolic
rate.
N Engl J Med.
1986;
315
96-100
- 5
Boss O, Samec S, Paoloni-Giacobino A. et al .
Uncoupling
protein-3: A new member of the mitochondrial carrier family with
tissue-specific expression.
FEBS Lett.
1997;
408
39-42
- 6
Bouchard C, Perusse L, Chagnon Y C, Warden C, Ricquier D.
Linkage between
markers in the vicinity of the uncoupling protein 2 gene and resting
metabolic rate in humans.
Hum Mol Genet.
1997;
6
1887-1889
- 7
Bouillaud F, Ricquier D, Thibault J, Weissenbach J.
Molecular approach
to thermogenesis in brown adipose tissue: cDNA cloning of the mitochondrial
uncoupling protein.
Proc Natl Acad Sci USA.
1985;
82
445-448
- 8
Bray G A, Blackburn G L, Ferguson J M. et al .
Sibutramine produces dose-related weight
loss.
Obes Res.
1999;
7
189-198
- 9
Camirand A, Marie V, Rabelo R, Silva J E.
Thiazolidinediones
stimulate uncoupling protein-2 expression in cell lines representing white
and brown adipose tissues and skeletal muscle.
Endocrinology.
1998;
139
428-431
- 10
Clapham J C, Arch J R, Chapman H. et al .
Mice overexpressing human uncoupling protein-3
in skeletal muscle are hyperphagic and lean.
Nature.
2000;
406
415-418
- 11
Clement K, Ruiz J, Cassard-Doulcier A M. et al .
Additive effect of A->G (-3826)variant
of the uncoupling protein gene and the Trp64Arg mutation of the
beta 3-adrenergic receptor gene on weight gain in morbid obesity.
Int
J Obes Relat Metab Disord.
1996;
20
1062-1066
- 12
Digby J E, Montague C T, Sewter C P. et al .
Thiazolidinedione exposure increases the
expression of uncoupling protein 1 in cultured human preadipocytes.
Diabetes.
1998;
47
138-141
- 13
Enerback S, Jacobsson A, Simpson E M. et al .
Mice lacking mitochondrial uncoupling protein
are cold-sensitive but not obese.
Nature.
1997;
387
90-94
- 14
Esterbauer H, Oberkofler H, Liu Y M. et al .
Uncoupling protein-1 mRNA expression in
obese human subjects: the role of sequence variations at the uncoupling
protein-1 gene locus.
J Lipid Res.
1998;
39
834-844
- 15
Fleury C, Neverova M, Collins S. et al .
Uncoupling protein-2: A novel gene linked
to obesity and hyperinsulinemia.
Nat Genet.
1997;
15
269-272
- 16
Garruti G, Ricquier D.
Analysis of uncoupling
protein and its mRNA in adipose tissue deposits of adult humans.
Int
J Obes Relat Metab Disord.
1992;
16
383-390
- 17
Gauthier C, Leblais V, Moniotte S, Langin D, Balligand J L.
The
negative inotropic action of catecholamines: role of beta3-adrenoceptors.
Can
J Physiol Pharmacol.
2000;
78
681-690
- 18
Gimeno R E, Dembski M, Weng X. et al .
Cloning and characterization of an uncoupling
protein homolog: a potential molecular mediator of human thermogenesis.
Diabetes.
1997;
46
900-906
- 19
Gong D W, He Y, Karas M, Reitman M.
Uncoupling
protein-3 is a mediator of thermogenesis regulated by thyroid hormone,
beta3-adrenergic agonists, and leptin.
J Biol Chem.
1997;
272
24 129-24 132
- 20
Gong D W, Monemdjou S, Gavrilova O. et al .
Lack of obesity and normal response to
fasting and thyroid hormone in mice lacking uncoupling protein-3.
J
Biol Chem.
2000;
275
16 251-16 257
- 21
Hamann A, Flier J S, Lowell B B.
Decreased
brown fat markedly enhances susceptibility to diet-induced obesity,
diabetes, and hyperlipidemia.
Endocrinology.
1996;
137
21-29
- 22
Hamann A, Matthaei S.
Braunes Fettgewebe
und Adipositas.
Diab Stoffw.
1995;
4
321-326
- 23
Hamann A, Tafel J, Busing B. et al .
Analysis of the uncoupling protein-1 (UCP1)
gene in obese and lean subjects: identification of four amino acid
variants.
Int J Obes Relat Metab Disord.
1998;
22
939-941
- 24
Hansen D L, Toubro S, Stock M J, Macdonald I A, Astrup A.
The
effect of sibutramine on energy expenditure and appetite during
chronic treatment without dietary restriction.
Int J Obes
Relat Metab Disord.
1999;
23
1016-1024
- 25
James W PT, Astrup A, Finer N. et al .
Effect of sibutramine on weight maintenance
after weight loss: A randomised trial.
Lancet.
2000;
356
2119-2125
- 26
Lean M E.
Sibutramine - a
review of clinical efficacy.
Int J Obes Relat Metab Disord.
1997;
21
S30-36
(Suppl 1)
- 27
Leibel R L, Rosenbaum M, Hirsch J.
Changes
in energy expenditure resulting from altered body weight.
N
Engl J Med.
1995;
332
621-628
- 28
Li B, Nolte L A, Ju J S. et al .
Skeletal
muscle respiratory uncoupling prevents diet-induced obesity and
insulin resistance in mice.
Nat Med.
2000;
6
1115-1120
- 29
Lowell B B, Spiegelman B M.
Towards
a molecular understanding of adaptive thermogenesis.
Nature.
2000;
404
652-660
- 30
Lowell B B, Susulic V S, Hamann A. et al .
Development of obesity in transgenic mice
following the genetic ablation of brown adipose tissue.
Nature.
1993;
366
740-742
- 31
Millet L, Vidal H, Andreelli F. et al .
Increased uncoupling protein-2 and -3 mRNA
expression during fasting in obese and lean humans.
J
Clin Invest.
1997;
100
2665-2670
- 32
Nordfors L, Hoffstedt J, Nyberg B. et al .
Reduced gene expression of UCP2 but not
UCP3 in skeletal muscle of human obese subjects.
Diabetologia.
1998;
41
935-939
- 33
Oberkofler H, Dallinger G, Liu Y M, Hell E, Krempler F, Patsch W.
Uncoupling protein gene:
quantification of expression levels in adipose tissues of obese
and non-obese humans.
J Lipid Res.
1997;
38
2125-2133
- 34
Oppert J M, Vohl M C, Chagnon M. et al .
DNA polymorphism in the uncoupling protein
(UCP) gene and human body fat.
Int J Obes Relat Metab
Disord.
1994;
18
526-531
- 35
Otabe S, Clement K, Dubois S. et al .
Mutation
screening and association studies of the human uncoupling protein
3 gene in normoglycemic and diabetic morbidly obese patients.
Diabetes.
1999;
48
206-208
- 36
Otabe S, Clement K, Rich N. et al .
Mutation
screening of the human UCP 2 gene in normoglycemic and NIDDM morbidly
obese patients: lack of association between new UCP 2 polymorphisms
and obesity in French Caucasians.
Diabetes.
1998;
47
840-842
- 37
Porter R K, Brand M D.
Body mass dependence
of H+ leak in mitochondria and its relevance to metabolic
rate.
Nature.
1993;
362
628-630
- 38
Ravussin E, Lillioja S, Knowler W C. et al .
Reduced rate of energy expenditure as a
risk factor for body-weight gain.
N Engl J Med.
1988;
318
467-472
- 39
Ricquier D, Bouillaud F.
The uncoupling protein
homologues: UCP1, UCP2, UCP3, StUCP and AtUCP.
Biochem
J.
2000;
345
161-179
- 40
Rosenbaum M, Leibel R L, Hirsch J.
Obesity.
N
Engl J Med.
1997;
337
396-407
- 41
Savontaus E, Rouru J, Boss O, Huupponen R, Koulu M.
Differential regulation
of uncoupling proteins by chronic treatments with beta 3-adrenergic
agonist BRL 35 135 and metformin in obese fa/fa
Zucker rats.
Biochem Biophys Res Commun.
1998;
246
899-904
- 42
Schrauwen P, Walder K, Ravussin E.
Human
uncoupling proteins and obesity.
Obes Res.
1999;
7
97-105
- 43 Schutz Y. Der
Energiestoffwechsel von Patienten mit Adipositas. In:
Wechsler JG. Adipositas Berlin, Wien: Blackwell
Wissenschafts-Verlag 1998: 93-103
- 44
Stock M J.
Sibutramine:
A review of the pharmacology of a novel anti-obesity agent.
Int
J Obes Relat Metab Disord.
1997;
21
S25-29
(Suppl 1)
- 45
Urhammer S A, Dalgaard L T, Sorensen T I. et al .
Mutational analysis of the coding region
of the uncoupling protein 2 gene in obese NIDDM patients: impact
of a common amino acid polymorphism on juvenile and maturity onset
forms of obesity and insulin resistance.
Diabetologia.
1997;
40
1227-1230
- 46
Vidal-Puig A, Rosenbaum M, Considine R C, Leibel R L, Dohm G L, Lowell B B.
Effects of
obesity and stable weight reduction on UCP2 and UCP3 gene expression
in humans.
Obes Res.
1999;
7
133-140
- 47
Vidal-Puig A, Solanes G, Grujic D, Flier J S, Lowell B B.
UCP3:
an uncoupling protein homologue expressed preferentially and abundantly
in skeletal muscle and brown adipose tissue.
Biochem Biophys
Res Commun.
1997;
235
79-82
- 48
Vidal-Puig A J, Grujic D, Zhang C Y. et al .
Energy metabolism in uncoupling protein
3 gene knockout mice.
J Biol Chem.
2000;
275
16 258-16 266
- 49
Walder K, Norman R A, Hanson R L. et al .
Association between uncoupling protein
polymorphisms (UCP2-UCP3) and energy metabolism/obesity
in Pima indians.
Hum Mol Genet.
1998;
7
1431-1435
- 50
Walsh K M, Leen E, Lean M E.
The
effect of sibutramine on resting energy expenditure and adrenaline-
induced thermogenesis in obese females.
Int J Obes Relat
Metab Disord.
1999;
23
1009-1015
- 51
Walston J, Silver K, Bogardus C. et al .
Time of onset of non-insulin dependent
diabetes mellitus and genetic variation in the β3-adrenergic
receptor gene.
N Engl J Med.
1995;
333
343-347
- 52
Weigle D S, Selfridge L E, Schwartz M W. et al .
Elevated free fatty acids induce uncoupling
protein 3 expression in muscle: a potential explanation for the
effect of fasting.
Diabetes.
1998;
47
298-302
- 53
Weyer C, Gautier J F, Danforth E Jr.
Development
of beta 3-adrenoceptor agonists for the treatment of obesity and
diabetes - an update.
Diabetes Metab.
1999;
25
11-21
- 54 Wirth A. Bewegungstherapie
bei Adipositas. In: Wechsler JG. Adipositas Berlin,
Wien: Blackwell Wissenschafts-Verlag 1998: 241-266
- 55
Wolman S I, Sheppard H, Fern M, Waterlow J C.
The effect
of tri-iodothyronine (T3) on protein turnover and metabolic rate.
Int
J Obes.
1985;
9
495-463
Korrespondenz
Dr. med. Andreas Hamann
Abteilung Innere Medizin I Medizinische Klinik
und Poliklinik Universitätsklinikum Heidelberg
Bergheimer Straße 58
69115 Heidelberg
Phone: 06221/568603
Fax: 06221/564036
Email: andreas_hamann@med.uni-heidelberg.de
